| Literature DB >> 26878849 |
Guotian Luo1, Ziqing Li1, Yu Wang2, Haixing Wang1, Ziji Zhang1, Weishen Chen1, Yangchun Zhang1, Yinbo Xiao1, Chaohong Li3, Ying Guo4, Puyi Sheng5.
Abstract
Aseptic implant loosening is closely associated with chronic inflammation induced by implant wear debris, and reactive oxygen species (ROS) play an important role in this process. Resveratrol, a plant compound, has been reported to act as an antioxidant in many inflammatory conditions; however, its protective effect and mechanism against wear particle-induced oxidative stress remain unknown. In this study, we evaluated resveratrol's protective effects against wear particle-induced oxidative stress in RAW 264.7 macrophages. At non-toxic concentrations, resveratrol showed dose-dependent inhibition of nitric oxide (NO) production, ROS generation, and lipid peroxidation. It also downregulated the gene expression of oxidative enzymes, including inducible nitric oxide synthase (iNOS) and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX)-1 and NOX-2, and promoted the gene expression and activities of antioxidant enzymes, including catalase (CAT), superoxide dismutase (SOD), glutathione reductase (GR), and glutathione peroxidase (GPx). This protective effect against wear particle-induced oxidative stress was accompanied by a reduction of gene expression and release of tumor necrosis factor-α (TNF-α), and decreased gene expression and phosphorylation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). These findings demonstrate that resveratrol can inhibit wear particle-induced oxidative stress in macrophages, and may exert its antioxidant effect and protect against aseptic implant loosening.Entities:
Keywords: aseptic loosening; chronic inflammation; oxidative stress; reactive oxygen species (ROS); resveratrol
Mesh:
Substances:
Year: 2016 PMID: 26878849 DOI: 10.1007/s10753-016-0306-6
Source DB: PubMed Journal: Inflammation ISSN: 0360-3997 Impact factor: 4.092